ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Oral Presentation
Chairs: R. Louis (Liège, Belgium), M. Saetta (Padova, PD, Italy)

Basal membrane biomarkers in stable and exacerbated COPD D. Schumann (Basel, Switzerland)
Blood biomarker algorithms to guide COPD assessment and risk stratification B. Masters (Billerica, United States of America)
IFNL3 polymorphisms are associated with COPD severity and outcomes D. Stolz (Basel, Switzerland)
Increased expression of Lysosomal-associated membrane protein 1 (LAMP-1) found in small airway epithelium of COPD may have functional consequence and role in autophagy. M. Eapen (Hobart, TAS, Australia)
Lung core-predominant emphysema is associated with higher symptom burden in COPD: analysis of the COPDGene cohort M. Han (Canada)
Sensitisation to Aspergillus fumigatus as a risk factor for bronchiectasis in COPD S. Everaerts (LEUVEN, Belgium)
Influence of bronchiectasis in patients hospitalized due to acute exacerbation of COPD. L. Ramirez Garcia (Madrid, Spain)
Serum Levels of Club-Cell Protein 16 (CC-16), Surfactant Protein D (SPD), soluble Receptor of Glycation End-products (sRAGE), Fibrinogen and C-Reactive Protein (CRP) and FEV1 Decline, Exacerbations and Mortality in SUMMIT B. Celli Croquer (Boston, United States of America)